Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir marboxil plus neuraminidase inhibitor vs placebo plus neuraminidase inhibitor in hospitalized severe influenza (Japan, Phase III)
jRCT2080224144Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Baloxavir marboxil + neuraminidase inhibitor with Placebo + neuraminidase inhibitor (2 arms). Started Nov 2018; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080224144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224144.